XTEK awarded $1.9 m Defence contract for SUAS parts
Defence contractor XTEK has received a $1.9 million order for Small Unmanned Aerial Systems (SUAS) spare parts as part of its role as prime system integrator on the Land 129-4A project.
Southport cannabis factory features in Canadian company’s global expansion
ASX-listed Epsilon Healthcare and Canadian company Valens have announced a partnership that will see the Australian company provide access to its cannabis manufacturing facility. Epsilon (formerly THC Group) runs a TGA and EU Good Manufacturing Practice-accredited facility in Southport, Queensland, the southern hemisphere’s largest cannabis extraction site. Under the partnership, products will be distributed in…
It’s time for Australia to develop its own guided missiles — otherwise, we’ll need to keep asking for the codes
Step by step, Australia is inching its way towards more autonomy in defence.
CSIRO launches $150 million food industry missions
CSIRO has launched three of what it calls ‘missions’ that will tackle food production issues, including developing new processed food export opportunities. The three missions will tackle drought, the food export market and growing the protein market. CSIRO Chief Executive Dr Larry Marshall said the three missions together aim to capture a $20 billion opportunity…
Orbital to expand Perth production facilities
Unmanned aircraft engine manufacturer Orbital UAV has begun an expansion of its Balcatta, Perth production facility following award of a defence global competitiveness grant. The company, whose export focus is two types of UAV engine produced for Boeing offshoot Insitu, will receive $195,000 under the recently-released grant. The cash will assist as the company begins…
IDT explains mRNA vaccine related share price rise
Comment by Peter Roberts Melbourne drug development and manufacturing company IDT Australia has again been asked by the stock exchange to explain a totally understandable surge in its share price in recent times. The background to this begins with the Australian government’s approach to market to ascertain potential sites where mRNA vaccine production could take…
Manufacturing news briefs – stories you might have missed
LGP to enter psychedelics market Cannabis producer Little Green Pharma has been granted a Schedule 9 licence by the Western Australian Department of Health to supply the psychedelic psilocybin to treat mental illness. LGB has established a special purpose subsidiary for psychedelic business which is planning to manufacture psilocybin in WA and conduct clinical trials.…